Lucio N. Gordan

2 weeks ago | blackchronicle.com | Lucio N. Gordan

Nearly every American’s life has been touched by cancer in some way. The American Cancer Society estimates more than 2 million people will be diagnosed with cancer in 2025, with over 171,000 of those cases in Florida. As an oncologist to the Florida community, I have seen that access to treatment, cost of care, and being close to supportive family and friends are critical factors in a patient’s fight against cancer. Community oncologists are focused on building trust with patients.

2 weeks ago | thecentersquare.com | Lucio N. Gordan

Nearly every American’s life has been touched by cancer in some way. The American Cancer Society estimates more than 2 million people will be diagnosed with cancer in 2025, with over 171,000 of those cases in Florida. As an oncologist to the Florida community, I have seen that access to treatment, cost of care, and being close to supportive family and friends are critical factors in a patient’s fight against cancer. Community oncologists are focused on building trust with patients.

2 months ago | onclive.com | Vivek Subbiah |Lucio N. Gordan

OpinionVideoFebruary 17, 2025Author(s):,Panelists discuss how in this discussion the top 3 key points were patient-centric care, enhanced multidisciplinary coordination, and increased access and equity. In the next 3 to 5 years there will be more decentralized testing, potentially more practices participating in genomic profiling, the cost of testing will go down and the turnaround time will be shorter.

2 months ago | onclive.com | Vivek Subbiah |Lucio N. Gordan

OpinionVideoFebruary 10, 2025Author(s):,Panelists discuss how decentralizing testing can address socioeconomic disparities by improving access to diagnostics for underserved populations. In-house testing reduces barriers like transportation challenges, lack of insurance, and limited availability of specialized tests, ensuring timely, equitable health care for all communities.

2 months ago | onclive.com | Vivek Subbiah |Lucio N. Gordan

OpinionVideoFebruary 10, 2025Author(s):,Panelists discuss how decentralizing biomarker testing improves access to targeted therapies and clinical trials for underserved populations by reducing geographic and systemic barriers, fostering equity in cutting-edge health care. Video series above is prompted by the following:What are your thoughts on how decentralization of biomarker testing might address access to targeted therapies and clinical trials in underserved populations?